Search Results
Avadomide 5 mg | Purity Not Available
TargetMol
CC-122 is an orally available pleiotropic pathway modulator with potential antineoplastic activity.
More Information Supplier PageAvadomide 10 mg | Purity Not Available
TargetMol
CC-122 is an orally available pleiotropic pathway modulator with potential antineoplastic activity.
More Information Supplier PageGSK269962A 5 mg | 98.63%
TargetMol
GSK269962 is a selective ROCK(Rho-associated protein kinase) inhibitor with IC50 values of 1.6 and 4 nM for ROCK1 and ROCK2, respectively.
More Information Supplier PageLys05 50 mg | Purity Not Available
TargetMol
Lys05, or Lys01 trihydrochloride, is a potent, water soluble lysosomal autophagy inhibitor. Lys05 is a previously undescribed dimeric chloroquine which more potently accumulates in the lysosome and blocks autophagy compared with HCQ. Lys05 produced more potent antitumor activity as a single agent both in vitro and in vivo in multiple human cancer cell lines and […]
More Information Supplier PageLys05 10 mg | Purity Not Available
TargetMol
Lys05, or Lys01 trihydrochloride, is a potent, water soluble lysosomal autophagy inhibitor. Lys05 is a previously undescribed dimeric chloroquine which more potently accumulates in the lysosome and blocks autophagy compared with HCQ. Lys05 produced more potent antitumor activity as a single agent both in vitro and in vivo in multiple human cancer cell lines and […]
More Information Supplier PageLys05 100 mg | Purity Not Available
TargetMol
Lys05, or Lys01 trihydrochloride, is a potent, water soluble lysosomal autophagy inhibitor. Lys05 is a previously undescribed dimeric chloroquine which more potently accumulates in the lysosome and blocks autophagy compared with HCQ. Lys05 produced more potent antitumor activity as a single agent both in vitro and in vivo in multiple human cancer cell lines and […]
More Information Supplier PagePardoprunox hydrochloride 5 mg | 98.73%
TargetMol
Pardoprunox hydrochloride is a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist, D2 (pKi = 8.1) and D3 receptor (pKi = 8.6) partial agonist and 5-HT1A receptor (pKi = 8.5) full agonist.
More Information Supplier PagePardoprunox hydrochloride 25 mg | 98.73%
TargetMol
Pardoprunox hydrochloride is a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist, D2 (pKi = 8.1) and D3 receptor (pKi = 8.6) partial agonist and 5-HT1A receptor (pKi = 8.5) full agonist.
More Information Supplier PagePardoprunox hydrochloride 10 mg | 98.73%
TargetMol
Pardoprunox hydrochloride is a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist, D2 (pKi = 8.1) and D3 receptor (pKi = 8.6) partial agonist and 5-HT1A receptor (pKi = 8.5) full agonist.
More Information Supplier Page